New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 17, 2014
16:41 EDTLH, DGXQuest Diagnostics annonces senior leadership appointments
Quest Diagnostics (DGX) announced a series of senior leadership appointments. John Haydon, Senior Vice President, Operations, has decided for family reasons to take a new position that requires less travel, and will transition to a new role as Vice President, Joint Ventures and Strategic Programs, the company said. James Davis, previously Senior Vice President, Diagnostic Solutions, will become Senior Vice President, Operations, succeeding Haydon. In addition, Lidia Fonseca will join Quest as Senior Vice President and Chief Information Officer, effective April 2. Fonseca previously was the Chief Information Officer at LabCorp (LH).
News For DGX;LH From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 18, 2014
09:07 EDTLHLabCorp announces availability of test to identify enterovirus D-68
LabCorp announced the availability of a reflex test to identify enterovirus D68, which is associated with severe respiratory illness that primarily affects children. The EV-D68 PCR test determines the presence or absence of enteroviral RNA in a respiratory sample, and if positive, reflexes to an EV-D68-specific PCR test. The EV-D68 subtyping PCR test enables the presence or absence of the predominant D68 strain to be determined.
06:18 EDTDGXRedHill Biopharma acquires techonology from University of Minnesota
RedHill Biopharma (RDHL) has entered into a license agreement with the University of Minnesota to acquire the rights to a patented technology to support the development of a commercial diagnostic test for detection of Mycobacterium avium subspecies paratuberculosis bacterium. RedHill's Crohn's disease program RHB-104, currently undergoing a first Phase III study, is based on evidence that Crohn's disease is caused by MAP infection in susceptible patients. As part of development for RHB-104, RedHill is developing, in collaboration with Quest Diagnostics (DGX), a diagnostic test to aid in detecting the presence of MAP in whole blood. RedHill will pay the University of Minnesota a one-time upfront payment and an additional potential milestone payment for the licensed technology. A pre-submission meeting with the FDA to discuss the development path for the diagnostic test is scheduled for January 2015.
December 16, 2014
08:46 EDTLHLabCorp, Covance announce expiration of Hart-Scott-Rodino waiting period
Subscribe for More Information
December 15, 2014
10:10 EDTLHHigh option volume stocks:
High option volume stocks: RVBD AGCO FRO CRUS UBNT LH PAY PETM OREX KOS
December 9, 2014
15:31 EDTLHLabCorp management to meet with Craig-Hallum
Meeting to be held in Baltimore on December 10 hosted by Craig-Hallum.
07:44 EDTDGXAmerican Association for Cancer Research to hold a symposium
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use